Validation-data analysis
Validation & data analysis We know that introducing a new software application into an organization working in a regulated environment involves many complex business processes and can be tedious and time-consuming. System validation Our dedicated validation specialists provide full validation service of our systems. We can help you lower validation costs using methods such as risk analysis, […]
Society of Toxicology conference 2024
SOT 2024 – Society Of Toxicology The 2024 Society of Toxicology (SOT) Conference Exhibition will take place in Salt Lake City, Utah at the Salt Palace Convention Center from March 10th to the 14th. Join us at booth #816-818 ! Hosted sessions We will be hosting free in-person sessions at the SOT 2024 Salt Palace Convention Center in Room […]
Using noninvasive impedance to assess respiratory function-registration
SOT 2024 – Hosted Session https://4484628.fs1.hubspotusercontent-na1.net/hubfs/4484628/Video%20emkaPACK%20and%20ECG.mp4 No cal? No problem! Using Non-invasive Impedance to Assess Respiratory Function March 12, 2024 – 12:00 noon – 01:00 PM in Room 155C Salt Palace Convention Center – Salt Lake City, Utah, USA Session description: The presentation will discuss evaluation of non-invasive impedance system for respiratory assessment, using emkaPACK […]
Resources
Resources Build on your knowledge of various topics in pre-clinical research. Filter applications Cardiovascular Medical Countermeasures Neurosciences Respiratory Safety pharmacology Toxicology
Interview with Kenta Nakamura
Dr. Nakamura is Director of Preclinical Research at the UW Medicine Heart Regeneration Program. This translational research focuses on pluripotent stem cell-based cardiac remuscularization therapies using various preclinical models to optimize the efficacy, safety, engraftment, and maturation of cardiomyocyte transplantation through novel genetic, metabolic, immunomodulatory, antiarrhythmic and delivery strategies.
press-release-Yael-Mamane
Le groupe emka TECHNOLOGIES/SCIREQ est fier d’accueillir Mme Yael Mamane au sein de son conseil d’administration. emka TECHNOLOGIES/SCIREQ group is proud to welcome Ms. Yael Mamane to its board of directors. Montréal, 30 Novembre, 2023 : Dr Yael Mamane est directrice principale du département de biologie cellulaire et des sciences translationnelles chez NuChem Sciences, un […]
Cardiomyopathy
Cardiomyopathy Cardiomyopathy is a group of diseases that affect the myocardium. The heart muscle becomes enlarged, thickened, or stiff, which can lead to problems with the heart’s ability to pump blood effectively, and can cause heart failure, cardiac fibrosis or arrhythmias. This condition can be caused by a variety of factors, including genetics (syndrome of […]
Taking advantage of new models and tools to rethink efficacy and Safety Research
During the 2023 Safety Pharmacology Society (SPS) Conference in Brussels, Dr. Dany Salvail (IPST, QC, Canada) explained how experienced pharmacologists rely on alternate models combined with sophisticated measurement techniques that go well beyond the ICH guidelines to help sponsors truly understand and quantify liabilities associated with their lead compounds early on.
Swine, the other tox species
During the 2023 Safety Pharmacology Society (SPS) Conference in Brussels, Dr. Donald Hodges (CBSET, MA, USA) outlined how proven translational characteristics and historical data are enabling the wider adoption of swine as an alternative to dogs and Non-Human Primates in the context of shortages and rising costs.
Use of the rat in cardiovascular screening assays
During the 2023 Safety Pharmacology Society (SPS) Conference in Brussels, Dr. Michael Stonerook (AmplifyBio, OH, USA) highlighted the benefits and limitations of the rat model for cardiovascular screening assays.
